STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Genmab
Incyte Corporation
St. Jude Children's Research Hospital
Alliance for Clinical Trials in Oncology
Mayo Clinic
St. Jude Children's Research Hospital
Checkpoint Therapeutics, Inc.
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Fate Therapeutics
Scripps Health
Incyte Corporation
Incyte Corporation
MultiVir, Inc.
Celgene
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Shenzhen BinDeBio Ltd.
University of Southern California
Daiichi Sankyo
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Celldex Therapeutics
Wake Forest University Health Sciences
University of Arizona
Novartis
Mirna Therapeutics, Inc.
Pfizer
Stanford University
Seagen Inc.
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
University of California, San Francisco
Northside Hospital, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Pfizer